This study demonstrates that electroacupuncture lowers hepatic ischemia-reperfusion injury markers in rats, suggesting a role for Esr1 and TAK1 in this process.
Key Points
Electroacupuncture treatment significantly reduced serum ALT and AST levels, indicating improved liver function.
Histological analysis showed decreased necrotic areas and apoptosis in electroacupuncture-treated liver tissues.
The study found that electroacupuncture inhibited the TAK1–JNK/p38 signaling pathway, leading to reduced hepatocyte apoptosis.
Findings indicate that electroacupuncture may serve as a therapeutic approach in managing hepatic ischemia-reperfusion injury.